- Home
- IMTE vs BDRX Comparison
IMTE vs BDRX Comparison
Compare IMTE & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- BDRX
- Stock Information
- Founded
- IMTE 2008
- BDRX 2000
- Country
- IMTE Malaysia
- BDRX United Kingdom
- Employees
- IMTE N/A
- BDRX N/A
- Industry
- IMTE Consumer Electronics/Appliances
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- BDRX Health Care
- Exchange
- IMTE Nasdaq
- BDRX Nasdaq
- Market Cap
- IMTE 4.1M
- BDRX 3.6M
- IPO Year
- IMTE N/A
- BDRX N/A
- Fundamental
- Price
- IMTE $1.12
- BDRX $1.15
- Analyst Decision
- IMTE
- BDRX
- Analyst Count
- IMTE 0
- BDRX 0
- Target Price
- IMTE N/A
- BDRX N/A
- AVG Volume (30 Days)
- IMTE 9.9K
- BDRX 3.6M
- Earning Date
- IMTE 06-17-2025
- BDRX 04-11-2025
- Dividend Yield
- IMTE N/A
- BDRX N/A
- EPS Growth
- IMTE N/A
- BDRX N/A
- EPS
- IMTE N/A
- BDRX N/A
- Revenue
- IMTE $123,337.00
- BDRX N/A
- Revenue This Year
- IMTE N/A
- BDRX N/A
- Revenue Next Year
- IMTE N/A
- BDRX N/A
- P/E Ratio
- IMTE N/A
- BDRX N/A
- Revenue Growth
- IMTE 4.75
- BDRX N/A
- 52 Week Low
- IMTE $0.51
- BDRX $1.01
- 52 Week High
- IMTE $3.17
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- IMTE 41.83
- BDRX 39.66
- Support Level
- IMTE $1.05
- BDRX $1.01
- Resistance Level
- IMTE $1.13
- BDRX $1.26
- Average True Range (ATR)
- IMTE 0.04
- BDRX 0.12
- MACD
- IMTE -0.00
- BDRX 0.01
- Stochastic Oscillator
- IMTE 35.00
- BDRX 15.22
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.